Development of an Anti-Viral coating for Pandemic Mitigation of COVID-19 using titanium dioxide nanoparticles
使用二氧化钛纳米粒子开发抗病毒涂层以缓解 COVID-19 疫情
基本信息
- 批准号:551074-2020
- 负责人:
- 金额:$ 3.64万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Alliance Grants
- 财政年份:2020
- 资助国家:加拿大
- 起止时间:2020-01-01 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
SARS-CoV-2 remains active on various surfaces for up to 72 hours creating a network of contaminated surfaces, enabling rapid spread of the virus. In this project we propose to address this issue by preventing the transition of the virus through surface contamination. we propose to design a new type of coating containing TiO2 nanoparticles which, under visible light, can annihilate the SARS-CoV-2 viruses that are attached to high risk surfaces via microdroplets or touch. This could significantly prevent cross-contamination and rapid spread of the virus. We will incorporate the photoactive TiO2 nanoparticles in the form of sprays and paint which are the two most-commonly used techniques for coating surfaces.
Consequently, the new type of coating can simply be applied to a variety of surfaces and already built-in parts such as knobs, handles, walls, ceilings, and biomedical instruments. TiO2 particles are photocatalytically active under UV irradiation and can photo-kill capsid proteins of SARS-CoV-2 viruses in a short time. Moreover, Titania is a low-cost material and possesses very low toxicity and high chemical stability. In order to induce photocatalytic properties in TiO2 nanoparticles under visible light, we will dope the particles with nitrogen using a single-step heat treatment technique.
In collaboration with our industry partner (Nanophyll Inc.) we are determined to design a pilot production line and rapidly commercialize our final product in the form of an antiviral paint or spray. Our industrial collaborator's considerable experience in developing and manufacturing smart coatings for bacteria and fouling resistant as well as self-cleaning, will greatly help with rapid commercialization of the developed coatings using the potential of Nanophyll's strategic partners.
SARS-CoV-2在各种表面上保持活性长达72小时,形成受污染表面的网络,使病毒能够迅速传播。在这个项目中,我们建议通过防止病毒通过表面污染的转移来解决这个问题。我们建议设计一种含有TiO2纳米粒子的新型涂层,该涂层在可见光下可以通过微滴或触摸消灭附着在高风险表面上的SARS-CoV-2病毒。这可以显著防止病毒的交叉污染和快速传播。我们将以喷雾和油漆的形式加入光活性TiO2纳米粒子,这是两种最常用的表面涂层技术。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Didar, Tohid其他文献
Didar, Tohid的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Didar, Tohid', 18)}}的其他基金
Engineering the bio-interface for the next generation of biomedical devices
设计下一代生物医学设备的生物界面
- 批准号:
RGPIN-2017-05254 - 财政年份:2022
- 资助金额:
$ 3.64万 - 项目类别:
Discovery Grants Program - Individual
Engineering the bio-interface for the next generation of biomedical devices
设计下一代生物医学设备的生物界面
- 批准号:
RGPIN-2017-05254 - 财政年份:2021
- 资助金额:
$ 3.64万 - 项目类别:
Discovery Grants Program - Individual
Developing novel smart biointerfaces for in vitro biosensing and point of care diagnostics
开发用于体外生物传感和护理诊断的新型智能生物接口
- 批准号:
537197-2018 - 财政年份:2021
- 资助金额:
$ 3.64万 - 项目类别:
Collaborative Research and Development Grants
Engineering the bio-interface for the next generation of biomedical devices
设计下一代生物医学设备的生物界面
- 批准号:
RGPIN-2017-05254 - 财政年份:2020
- 资助金额:
$ 3.64万 - 项目类别:
Discovery Grants Program - Individual
Developing novel smart biointerfaces for in vitro biosensing and point of care diagnostics
开发用于体外生物传感和护理诊断的新型智能生物接口
- 批准号:
537197-2018 - 财政年份:2020
- 资助金额:
$ 3.64万 - 项目类别:
Collaborative Research and Development Grants
Engineering the bio-interface for the next generation of biomedical devices
设计下一代生物医学设备的生物界面
- 批准号:
RGPIN-2017-05254 - 财政年份:2019
- 资助金额:
$ 3.64万 - 项目类别:
Discovery Grants Program - Individual
Developing novel smart biointerfaces for in vitro biosensing and point of care diagnostics
开发用于体外生物传感和护理诊断的新型智能生物接口
- 批准号:
537197-2018 - 财政年份:2019
- 资助金额:
$ 3.64万 - 项目类别:
Collaborative Research and Development Grants
相似国自然基金
基于spA-Gel负载Anti-HMGB1原位靶向免疫耐受的猪胰岛类器官移植研
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
肺癌外周血淋巴细胞亚群预测anti-PD1/PDL1疗效的鉴定及应用研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
TKIs氘代化修饰通过促进HCC铁死亡增强免疫原性并增敏anti-PD-1治疗的机制研究
- 批准号:JCZRQN202500319
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
Anti-MDA5阳性皮肌炎病人的NK细胞数量与功能改变在间质性肺疾病中的作用与机制研究
- 批准号:MS25H100014
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
特发性膜性肾病血清标志物anti-PLA2R-IgG4检测方法的建立及临床应用
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
经 anti-GPC3 修饰的外泌体靶向递送索拉非尼与放疗联合诱
导肝细胞癌铁死亡的研究
- 批准号:2024JJ9608
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
CCL2介导PGK1的O-GlcNAc糖基化修饰诱导CAFs代谢重编程促进头颈癌anti-PD-1免疫治疗耐药的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
千金藤素通过自噬损伤导致的免疫原性细胞死亡促进 anti-PD1 治疗MSS 型结直肠癌的疗效与机制研究
- 批准号:
- 批准年份:2024
- 资助金额:10.0 万元
- 项目类别:省市级项目
周细胞 ZEB1/SPP1 旁分泌轴招募 MDSCs 诱导
卵巢癌 anti-PD1/PD-L1 疗法耐药的机制研究
- 批准号:Y24H310009
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
肿瘤相关成纤维细胞通过 YAP/CXCL12 信号
轴调控 B 细胞功能介导肝癌anti-PD1治疗抵
抗的机制研究
- 批准号:TGY24H160070
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
Development of sensitive molecular viral assays to screen anti-SARS-CoV-2 formulations
开发敏感的分子病毒检测方法来筛选抗 SARS-CoV-2 制剂
- 批准号:
2749637 - 财政年份:2022
- 资助金额:
$ 3.64万 - 项目类别:
Studentship
Development of novel anti-viral therapeuticing an advanced screening technologys us
利用先进的筛选技术开发新型抗病毒疗法
- 批准号:
22KK0112 - 财政年份:2022
- 资助金额:
$ 3.64万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))
COVID-19 Variant Supplement - Towards anti-COVID-19 therapeutic development by targeting the viral papain-like proteinase
COVID-19 变异补充剂 - 通过靶向病毒木瓜蛋白酶样蛋白酶来开发抗 COVID-19 疗法
- 批准号:
443281 - 财政年份:2021
- 资助金额:
$ 3.64万 - 项目类别:
Operating Grants
SBIR Phase I: Development of a novel peptide inhibitor of coronavirus papain-like protease as a prophylactic and anti-viral therapeutic for COVID19, administered by inhalation
SBIR 第一阶段:开发新型冠状病毒木瓜蛋白酶肽抑制剂,作为 COVID19 的预防和抗病毒治疗剂,通过吸入给药
- 批准号:
2036294 - 财政年份:2021
- 资助金额:
$ 3.64万 - 项目类别:
Standard Grant
Towards anti-COVID-19 therapeutic development by targeting the viral papain-like proteinase
通过靶向病毒木瓜蛋白酶样蛋白酶来开发抗 COVID-19 疗法
- 批准号:
422703 - 财政年份:2020
- 资助金额:
$ 3.64万 - 项目类别:
Operating Grants
The development of a new, highly-efficacious, 100% natural, anti-viral active ingredient
%20开发%20%20a%20新、%20高效、%20100%%20天然、%20抗病毒%20活性%20成分
- 批准号:
47612 - 财政年份:2020
- 资助金额:
$ 3.64万 - 项目类别:
Study
The development of a nanotechnology enabled anti-viral face mask (NanoMask)
开发纳米技术抗病毒口罩(NanoMask)
- 批准号:
63429 - 财政年份:2020
- 资助金额:
$ 3.64万 - 项目类别:
Feasibility Studies
Development of anti-HIV drug to induce apoptosis by accumulation of viral protein
开发抗HIV药物通过病毒蛋白积累诱导细胞凋亡
- 批准号:
17J11657 - 财政年份:2017
- 资助金额:
$ 3.64万 - 项目类别:
Grant-in-Aid for JSPS Fellows
A proteome-wide approach to anti-viral immunity and vaccine development
抗病毒免疫和疫苗开发的全蛋白质组方法
- 批准号:
nhmrc : GNT1104329 - 财政年份:2016
- 资助金额:
$ 3.64万 - 项目类别:
Research Fellowships
A proteome-wide approach to anti-viral immunity and vaccine development
抗病毒免疫和疫苗开发的全蛋白质组方法
- 批准号:
nhmrc : 1104329 - 财政年份:2016
- 资助金额:
$ 3.64万 - 项目类别:
Research Fellowships